Bellevue Group’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
Bellevue Group's GH Position: Q3 2026 in Review
Bellevue Group opened a new position in Guardant Health (GH) in Q3 2026: 6,196 shares worth $1.11M. The stake represents 0.02% of the portfolio and ranks #101 among its holdings. This is a return to the name: Bellevue Group previously reported a position in GH as recently as Q4 2025.
Bellevue Group first reported a position in GH in Q4 2018 and has held it in 23 quarters since. The position peaked at $47.1M in Q2 2021. 673 funds tracked by Wall St. Rank hold GH as of Q3 2026.
- Bellevue Group held 6,196 shares of Guardant Health worth $1.11M as of Q3 2026.
- Guardant Health was a new Bellevue Group position in Q3 2026.
- Guardant Health made up 0.02% of Bellevue Group's portfolio in Q3 2026, its #101 holding.
- Bellevue Group first reported a position in Guardant Health in Q4 2018 and has held it in 23 quarters since.
- Bellevue Group's Guardant Health position peaked at $47.1M in Q2 2021.
- 673 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.
Based on Bellevue Group's 13F filing for Q3 2026, filed 16 Nov 2026.